Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide. The company collaborates with Canadian academic and medical institutions. Its scientific platform includes research and development, and clinical development that leads to the commercialization of approximately twenty products across four main market segments. The company provides medical and wellness products containing cannabidiol, cannabigerol, and tetrahydrocannabinol under the RHO Phyto brand; functional CBD consumer derma-cosmetic and topical products under the Pura H&W and Pura Earth brand names; and cannabis dried flowers, standardized seeds, full spectrum extracts, cannabinoid distillates, isolated cannabinoids, and bulk formulations derived from hemp and cannabis cultivars under the Aureus brand. It also develops pharmaceutical products for epidermolysis bullosa, dermatology, chronic pain, and various neurological disorders. The company has research collaboration with Dr. Christine Allen'sResearch Group for the development of a cannabinoid-based treatment for lung inflammation associated with COVID19. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada.

Dr. Frantz Le Devedec

Executive Vice President of Research & Development

Mr. Stephen  Kim

Chief Legal Officer & General Counsel of Avicanna USA Inc.

Mr. Aras  Azadian B.Econ, Mba

Co-Founder, Chief Executive Officer & Director

Ms. Ingrid  Diaz

Vice President, Assistant General Counsel & Corporate Compliance Officer

Ms. Ivana  Maric

Executive Vice President of Marketing

Mr. Enric  Pujol

Vice President of People

Dr. Karolina  Urban

Executive Vice President of Scientific & Medical Affairs

Mr. Arash  Moghani MBA

Executive Vice President of Operations & Technology

Mr. Phillip  Cardella C.A., CPA

Chief Financial Officer

Dr. Carlos Enrique Maldonado Muete

SVice President of Clinical Development

Avicanna Inc.

Avicanna Inc. Structure de gestion

Informations sur la direction